About Kura Oncology (KURA)
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company. The Company’s segment is engaged in discovery and development of medicines for the treatment of cancer. Its pipeline consists of small molecule product candidates that target cancer s... Read more
- USD18.75
- USD18.82
- USD18.65
- USD24.17
- -12.50%
- --
- 9.64k
- 873.94k
- 1.3B
- 7.41
- 70.30%
Stock News
1 hour ago
U.S. crude oil pulls back below $83 a barrel as brief rally stalls out
CNBC
1 hour ago
Blackstone Mortgage Trust Reports Q1 2024 Results: A Mixed Financial Performance
Yahoo
1 hour ago
Evercore Inc (EVR) Q1 2024 Earnings: Meets EPS Estimates, Reports Modest Revenue Growth
Yahoo
1 hour ago
$433 Billion Gone! One Stock Loses More Value Than Tesla
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
